Previous Article | Next Article ![]()
Infect Immun, July 1998, p. 3279-3289, Vol. 66, No. 7
Infectious Disease Research
Institute,1
Corixa
Corporation,2 and
Department of Pathobiology,
University of Washington,4 Seattle, Washington,
and
Federal University of Bahia, Salvador, Bahia,
Brazil3
Received 21 January 1998/Returned for modification 4 March
1998/Accepted 20 April 1998
Vaccination of BALB/c mice with Leishmania major
promastigote culture filtrate proteins plus Corynebacterium
parvum confers resistance to infection with L. major.
To define immunogenic components of this protein mixture, we used sera
from vaccinated mice to screen an L. major amastigote cDNA
expression library. One of the immunoreactive clones thus obtained
encoded a novel protein of L. major with a molecular mass
of 22.1 kDa. The predicted amino acid sequence of this clone exhibited
significant homology to eukaryotic thiol-specific-antioxidant (TSA)
proteins. Therefore, we have designated this protein L. major TSA protein. Southern blot hybridization analyses indicate
that there are multiple copies of the TSA gene in all species of
Leishmania analyzed. Northern blot analyses demonstrated
that the TSA gene is constitutively expressed in L. major
promastigotes and amastigotes. Recombinant TSA protein containing an
amino-terminal six-histidine tag was expressed in Escherichia
coli with the pET17b system and was purified to homogeneity by
affinity chromatography. Immunization of BALB/c mice with recombinant
TSA protein resulted in the development of strong cellular immune
responses and conferred protective immune responses against infection
with L. major when the protein was combined with
interleukin 12. In addition, recombinant TSA protein elicited in vitro
proliferative responses from peripheral blood mononuclear cells of
human leishmaniasis patients and significant TSA protein-specific
antibody titers were detected in sera of both cutaneous-leishmaniasis
and visceral-leishmaniasis patients. Together, these data suggest that
the TSA protein may be useful as a component of a subunit vaccine
against leishmaniasis.
0019-9567/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
Human and Murine Immune Responses to a Novel
Leishmania major Recombinant Protein Encoded by Members
of a Multicopy Gene Family

*
Corresponding author. Mailing address: Infectious
Disease Research Institute, 1124 Columbia St., Suite 200, Seattle, WA 98104. Phone: (206) 754-5712. Fax: (206) 754-5715. E-mail:
reed{at}corixa.com.
Present address: Department of Microbiology and Immunology,
University of Ottawa, Ottawa, Ontario, Canada.
This article has been cited by other articles:
| J. Bacteriol. | J. Virol. | Eukaryot. Cell |
|---|
| Microbiol. Mol. Biol. Rev. | Clin. Vaccine Immunol. | All ASM Journals |
|---|